News Center

Combining mutually informative AI "dry lab" algorithms with large-scale "wet lab" robotics to empower pharmaceutical innovation

Shenzhen, CHINA – January 11th , 2023 – XtalPi, Inc., a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, announced that Dr. Sarah Trice has joined...

XtalPi, Inc. announced a research collaboration with Janssen Pharmaceutica NV to deliver chemical matter with validated binding affinities and desirable property profiles.

Cambridge, MA and Shenzhen, China – March 7, 2022 – XtalPi, a pioneering artificial intelligence (AI) drug research and development (R&D) company today announced that it has been named by Fierce Medtech as one of 2021's Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry.

SHENZHEN, China & BOSTON - Signet Therapeutics and XtalPi Inc., a physics-based, AI-powered drug R&D company, announced the expansion of their AI drug discovery collaboration to include a new first-in-class program against a novel cancer target identified by Signet.

XtalPi, a leading AI drug discovery company, announces a research collaboration with Acerand Therapeutics, a biotechnology company specialized in developing best-in-class and or first-in-class drugs. The partnership will leverage XtalPi's highly accurate physics-based models and machine learning models to develop potential novel chemical entities for a cancer target.